Saturday 23 February 2019

Officials at the event

Julphar receives Russian delegation

DUBAI, October 15, 2017

UAE-based Julphar, a leading pharmaceutical company in the region, recently received Gocha Buachidze, Consul General of the Russian Federation, accompanied by a delegation representing Russian healthcare companies.

The visit was aimed at reviewing Julphar’s extensive experience in Middle East and North Africa (Mena) pharmaceutical industry and to discuss potential mutual cooperation, said a statement from the company.

The high-quality medicines manufactured by Julphar are recognised as strong brands with an international presence, as they are distributed to over 40 countries and provide effective treatment for a wide range of conditions, especially chronic diseases, it said.

Sheikh Faisal Bin Saqr Al Qassimi, chairman of the board of Julphar, said: “The visit by the Russian delegation reflects our growing relations and the determination of both parties to reinforce cooperation in the healthcare sector.”

Jerome Carle, general manager, Julphar, said: “The visit of the Russian delegation was an opportunity to demonstrate our numerous initiatives and efforts to enhance production facilities, state-of-the-art platforms for scientific research and technical development.”

“With more than 200 products available in our portfolio, we believe we can contribute strongly to improve access to quality and affordable treatments for patients around the world, especially in the field of diabetes management,” he said.

Al Qassimi briefed the visiting delegation about the company’s history, which started out as a standalone facility in 1980, and its ongoing commitment to implement the highest standards in pharmaceutical manufacturing, said a statement.

He also shed the light on the company’s pioneering initiatives that garnered local and international consumers’ confidence and its strong presence in Middle East and Africa (MEA).

The Consul General of the Russian Federation expressed his deep admiration for the significant achievements made by the company in the field of biotechnology with Insulin and Epotin.

Buachidze said: “Meeting with Al Qassimi has been an important opportunity to learn about Julphar, which is one of the most renowned and important drug manufacturer in the region, and to discuss ways to boost coordination, cooperation and promote mutual relations.”

Following the reception, members of the delegation had the opportunity to visit Julphar XI, which is one of the most modern biotechnological plant in the region, it stated. – TradeArabia News Service

Tags: | Russia | Delegation | Julphar |

More Industry, Logistics & Shipping Stories

calendarCalendar of Events